Literature DB >> 17489578

SHOP: scaffold HOPping by GRID-based similarity searches.

Rikke Bergmann1, Anna Linusson, Ismael Zamora.   

Abstract

A new GRID-based method for scaffold hopping (SHOP) is presented. In a fully automatic manner, scaffolds were identified in a database based on three types of 3D-descriptors. SHOP's ability to recover scaffolds was assessed and validated by searching a database spiked with fragments of known ligands of three different protein targets relevant for drug discovery using a rational approach based on statistical experimental design. Five out of eight and seven out of eight thrombin scaffolds and all seven HIV protease scaffolds were recovered within the top 10 and 31 out of 31 neuraminidase scaffolds were in the 31 top-ranked scaffolds. SHOP also identified new scaffolds with substantially different chemotypes from the queries. Docking analysis indicated that the new scaffolds would have similar binding modes to those of the respective query scaffolds observed in X-ray structures. The databases contained scaffolds from published combinatorial libraries to ensure that identified scaffolds could be feasibly synthesized.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17489578     DOI: 10.1021/jm061259g

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  ParaFrag--an approach for surface-based similarity comparison of molecular fragments.

Authors:  Arjen-Joachim Jakobi; Harald Mauser; Timothy Clark
Journal:  J Mol Model       Date:  2008-05-01       Impact factor: 1.810

2.  Molecular Scaffold Hopping via Holistic Molecular Representation.

Authors:  Francesca Grisoni; Gisbert Schneider
Journal:  Methods Mol Biol       Date:  2021

3.  A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields.

Authors:  Fabio Broccatelli; Emanuele Carosati; Annalisa Neri; Maria Frosini; Laura Goracci; Tudor I Oprea; Gabriele Cruciani
Journal:  J Med Chem       Date:  2011-02-22       Impact factor: 7.446

Review 4.  Classification of scaffold-hopping approaches.

Authors:  Hongmao Sun; Gregory Tawa; Anders Wallqvist
Journal:  Drug Discov Today       Date:  2011-10-26       Impact factor: 7.851

5.  QSAR modeling and in silico design of small-molecule inhibitors targeting the interaction between E3 ligase VHL and HIF-1α.

Authors:  Jing Pan; Yanmin Zhang; Ting Ran; Anyang Xu; Xin Qiao; Lingfeng Yin; Weineng Zhou; Lu Zhu; Junnan Zhao; Tao Lu; Yadong Chen; Yulei Jiang
Journal:  Mol Divers       Date:  2017-07-08       Impact factor: 2.943

6.  In Silico Drug Discovery for Treatment of Virus Diseases.

Authors:  Shikha Joon; Rajeev K Singla; Bairong Shen
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

7.  De novo design of N-(pyridin-4-ylmethyl)aniline derivatives as KDR inhibitors: 3D-QSAR, molecular fragment replacement, protein-ligand interaction fingerprint, and ADMET prediction.

Authors:  Yanmin Zhang; Haichun Liu; Yu Jiao; Haoliang Yuan; Fengxiao Wang; Shuai Lu; Sihui Yao; Zhipeng Ke; Wenting Tai; Yulei Jiang; Yadong Chen; Tao Lu
Journal:  Mol Divers       Date:  2012-10-23       Impact factor: 2.943

8.  Molecular shape and medicinal chemistry: a perspective.

Authors:  Anthony Nicholls; Georgia B McGaughey; Robert P Sheridan; Andrew C Good; Gregory Warren; Magali Mathieu; Steven W Muchmore; Scott P Brown; J Andrew Grant; James A Haigh; Neysa Nevins; Ajay N Jain; Brian Kelley
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

Review 9.  Structure and ligand based drug design strategies in the development of novel 5- LOX inhibitors.

Authors:  Polamarasetty Aparoy; Kakularam Kumar Reddy; Pallu Reddanna
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

10.  Fragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitors.

Authors:  Ross G Douglas; Rajni K Sharma; Geoffrey Masuyer; Lizelle Lubbe; Ismael Zamora; K Ravi Acharya; Kelly Chibale; Edward D Sturrock
Journal:  Clin Sci (Lond)       Date:  2014-02       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.